Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Neurological disorders
Jan 21, 2020
Clene Nanomedicine Announces First Patient Dosed in the RESCUE-ALS Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8
Jan 14, 2020
ALS Association Makes Multi-Year Commitment to HEALEY ALS Platform Trial
Jan 13, 2020
MDA Awards Venture Philanthropy Funding of More Than $1M to AavantiBio to Develop Gene-Targeting Therapy for Friedreich's Ataxia
Jan 13, 2020
PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference
Jan 09, 2020
Mercaptor Discoveries Announces Preclinical Program in Epilepsy
Jan 09, 2020
Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio(TM)
Jan 07, 2020
Ionis' neurological franchise marks year of achievement
Jan 06, 2020
Kadimastem Announces Promising Results of Cohort A of its Phase 1/2a Clinical Trial in ALS
Dec 24, 2019
Spinal Muscular Atrophy: Forecast in Asia-Pacific Markets to 2028
Dec 23, 2019
Allergan Receives U.S. FDA Approval for UBRELVY(TM) for the Acute Treatment of Migraine with or without Aura in Adults
Dec 23, 2019
Kadimastem Announces the Completion of Treatment for Cohort B of Its Phase 1/2a Clinical Trial in ALS Patients
Dec 18, 2019
Lilly Announces the Launch of TRIUMPH, the First, Long-Term, Real-World Evidence Study of Emgality® (galcanezumab-gnlm)
Dec 17, 2019
Biohaven Achieves Positive Topline Results in Pivotal Phase 2/3 Study of Vazegepant, The First and Only Intranasal CGRP Receptor Antagonist in Clinical Development for the Acute Treatment of Migraine
Dec 16, 2019
BOTOX® (onabotulinumtoxinA) Celebrates 30 Years of Endless Innovation
Dec 13, 2019
MDA Celebrates FDA Approval of Vyondys 53 for Treatment of DMD Amenable to Exon 53 Skipping
Dec 13, 2019
ITF Pharma Announces FDA Approval of Supplemental New Drug Application (sNDA) for TIGLUTIK® (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) with a Percutaneous Endoscopic Gastronomy (PEG) Feeding Tube
Dec 11, 2019
Philip M. Gattone to Step Down as President & CEO of the Epilepsy Foundation
Dec 10, 2019
Answer ALS and Avanade harness technology to accelerate largest-ever ALS research program
Dec 09, 2019
Muscular Dystrophy Association Names Sharon Hesterlee, Ph.D., Executive Vice President, Chief Research Officer
Dec 09, 2019
HIZENTRA® (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
‹‹
Page 3
››
Latest News
Apr 25, 2024
The Spaceport Company Signs Agreement with Maritime Launch to Provide Tracking and Telemetry Stations for...
Apr 25, 2024
Intevac Announces First Quarter 2024 Financial Results
Apr 25, 2024
Expro Group Holdings N.V. Announces First Quarter 2024 Results
Apr 25, 2024
Laser Photonics’ Laser Technology Meets Unique Cleaning Needs of Precision Optics Manufacturers
Apr 25, 2024
LiveWire Group, Inc. Reports 2024 First Quarter Financial Results
Apr 25, 2024
LSI Industries Reports Fiscal 2024 Third Quarter Results and Declares Quarterly Cash Dividend
Apr 25, 2024
Janus International Group to Report First Quarter 2024 Results on May 9, 2024
Apr 25, 2024
Trane Technologies Recognized as One of Europe’s Climate Leaders by Financial Times
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events